Authors: Szeki, Iren; Hutchison, Alastair

Source: Expert Review of Endocrinology and Metabolism, Volume 4, Number 4, July 2009 , pp. 307-316(10)

Publisher: Expert Reviews

Abstract:

Reduced renal excretion of phosphate leads to hyperphosphatemia, which is prevalent in patients with end-stage renal disease, and is associated with increased morbidity and mortality. Dialysis alone is unable to adequately remove the ingested phosphate contained in food. It is therefore usually necessary to supplement food with drugs that reduce the intestinal absorption of dietary phosphate in order to control serum phosphate. Lanthanum carbonate is a recently introduced nonaluminum, noncalcium phosphate binder licensed for the management of serum phosphate in end-stage renal failure. It appears safe and effective, with data demonstrating no toxic effects in man after continuous exposure for up to 6 years. It is well tolerated and has a positive effect on bone histology in the context of renal osteodystrophy. Lanthanum carbonate's high affinity for phosphate rapid binding, palatability, low pill burden and absence of evident toxicity compare favorably with what are considered to be the ideal characteristics of an oral phosphate binder.

Keywords: chronic kidney disease; CKD; dialysis; ESRF; Fosrenol®; hyperphosphatemia; lanthanum carbonate; phosphate

Document Type: Research article

DOI: http://dx.doi.org/10.1586/eem.09.11

Affiliations: 1: Manchester Institute of Nephrology and Transplantation, The Royal Infirmary, Oxford Road, Manchester, M13 9WL, UK., Email: iren.szeki@cmft.nhs.uk

Publication date: 2009-07-01

More about this publication?

• Expert Review of Endocrinology & Metabolism provides extensive coverage of state-of-the-art research and clinical advancements in the field of endocrine control and metabolism, with a focus on screening, prevention, diagnostics, existing and novel therapeutics, as well as related molecular genetics, pathophysiology and epidemiology
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• Free Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Medicine ,  Medicine (General)
• By this author: Szeki, Iren ;  Hutchison, Alastair

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers